PHENYTOIN CAUSES A RAPID INCREASE IN 6-BETA-HYDROXYCORTISOL URINARY-EXCRETION IN HUMANS - A PUTATIVE MEASURE OF CYP3A INDUCTION

被引:66
作者
FLEISHAKER, JC [1 ]
PEARSON, LK [1 ]
PETERS, GR [1 ]
机构
[1] UPJOHN CO,CLIN RES UNIT,KALAMAZOO,MI 49007
关键词
D O I
10.1002/jps.2600840305
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
This study was conducted in eight healthy volunteers to assess the time course of induction of cytochrome P-450 by phenytoin. Subjects received 200 mg of phenytoin every 8 h for 11 doses and 100 mg every 8 h for 8 doses. Trough concentrations of phenytoin in plasma were measured by HPLC, Urine samples were collected between 08:00 and 12:00 on days -1, 1, 2, 3, 4, 5, and 7. Urinary concentrations of 6 beta-hydroxycortisol (6 beta-OHC) and cortisol (C) were determined by HPLC and were reported as a ratio (6 beta-OHC/C); this ratio is a marker for the 3A isozyme family of cytochrome P-450 (CYP3A). Mean plasma phenytoin concentrations on day 7 were 15.4 +/- 7.20 mu g/mL. Mean 6 beta-OHC/C ratios increased by a factor of 2.37 from baseline during the course of the study. Values for the ratios on days 4, 5, and 7 were significantly higher than baseline by Dunnett's test (one-sided) (p < 0.05); the day 3 value was borderline statistically significant. These results show that phenytoin rapidly induces the activity of the CYP3A family of isozymes, with effects apparent within 48 h after the initiation of phenytoin therapy.
引用
收藏
页码:292 / 294
页数:3
相关论文
共 8 条
[1]   ENZYME-INDUCTION AND INHIBITION [J].
BARRY, M ;
FEELY, J .
PHARMACOLOGY & THERAPEUTICS, 1990, 48 (01) :71-94
[2]   CIGARETTE-SMOKING AND THEOPHYLLINE METABOLISM - EFFECTS OF PHENYTOIN [J].
CROWLEY, JJ ;
CUSACK, BJ ;
JUE, SG ;
KOUP, JR ;
VESTAL, RE .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 42 (03) :334-340
[3]   THE EFFECT OF PHENYTOIN ON THE PHARMACOKINETICS OF TIRILAZAD MESYLATE IN HEALTHY MALE-VOLUNTEERS [J].
FLEISHAKER, JC ;
HULST, LK ;
PETERS, GR .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 56 (04) :389-397
[4]   THE INCREASE IN URINARY-EXCRETION OF 6-BETA-HYDROXYCORTISOL AS A MARKER OF HUMAN HEPATIC CYTOCHROME-P450IIIA INDUCTION [J].
GED, C ;
ROUILLON, JM ;
PICHARD, L ;
COMBALBERT, J ;
BRESSOT, N ;
BORIES, P ;
MICHEL, H ;
BEAUNE, P ;
MAUREL, P .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 28 (04) :373-387
[5]  
HANSEN JM, 1971, ACTA MED SCAND, V189, P15
[6]   ABSENCE OF CORRELATIONS AMONG 3 PUTATIVE IN-VIVO PROBES OF HUMAN CYTOCHROME-P4503A ACTIVITY IN YOUNG HEALTHY-MEN [J].
KINIRONS, MT ;
OSHEA, D ;
DOWNING, TE ;
FITZWILLIAM, AT ;
JOELLENBECK, L ;
GROOPMAN, JD ;
WILKINSON, GR ;
WOOD, AJJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 54 (06) :621-629
[7]   PHARMACOKINETIC DRUG-INTERACTIONS WITH PHENYTOIN .2. [J].
NATION, RL ;
EVANS, AM ;
MILNE, RW .
CLINICAL PHARMACOKINETICS, 1990, 18 (02) :131-150
[8]   URINARY-EXCRETION OF 6-BETA-HYDROXYCORTISOL AND THE TIME COURSE MEASUREMENT OF ENZYME-INDUCTION IN MAN [J].
OHNHAUS, EE ;
BRECKENRIDGE, AM ;
PARK, BK .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 36 (01) :39-46